C&CAUSES & WHAT WE KNOW
Causes & What We Know/August 2, 2026/2 min read

Scientists Discover Protein Patterns That May Explain Heart Disease Risk in Type 1 Diabetes

A new study identified three distinct groups of proteins in the blood that appear linked to coronary artery disease decades into life with type 1 diabetes. The findings suggest inflammation and metabolic processes work together in ways researchers are only beginning to understand.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

causesautoimmunitygeneticsrisk

Key takeaways

  • Researchers used advanced protein-scanning technology to study 417 people with childhood-onset type 1 diabetes over 30 years, finding that more than one-third developed serious heart disease
  • Three distinct protein patterns emerged, each connected to different biological processes: inflammatory signaling, metabolic and cell death processes, and blood clotting
  • The study suggests that blood sugar control (measured by HbA1c) may increase heart disease risk partly through these protein pathways, though the exact mechanisms need further investigation
  • This systems-level approach moves beyond studying single proteins, revealing the complex interplay of multiple biological systems in heart disease development

Why This Research Matters

People with type 1 diabetes face higher risk of coronary artery disease—the buildup of plaque in heart arteries—compared to people without diabetes. Scientists have long suspected that inflammation plays a role, but most previous studies looked at just a few proteins at a time. This new research takes a broader view, examining 184 different proteins circulating in the blood to understand how they work together.

Understanding these protein patterns may eventually help doctors identify who is at greatest risk and potentially develop new ways to protect the heart in type 1 diabetes.

What the Study Found

Researchers followed 417 people with type 1 diabetes diagnosed in childhood for 30 years, collecting blood samples early in the study period. Over those three decades, 151 participants (36.2%) developed serious coronary artery disease, including heart attacks, blocked arteries requiring treatment, or heart-related death.

Using advanced protein analysis, the team identified three distinct protein groups: one enriched with inflammatory proteins involved in immune cell activation and cell death; another linked to fat metabolism and cell death processes; and a third connected to blood clotting. Each protein group showed different connections to heart disease risk.

Blood Sugar Control and Heart Disease: A Protein Link?

The study explored whether blood sugar control—measured by HbA1c levels—influences heart disease risk through these protein pathways. The findings suggest that worse blood sugar control may increase heart disease risk at least partly by altering these protein patterns, though the full picture remains incomplete.

This doesn't mean the proteins cause heart disease directly. Rather, they appear to be markers of underlying biological changes that accompany high blood sugar and contribute to heart disease development. Further research is needed to understand these relationships.

What Comes Next

This foundational research opens new questions. Scientists will need to understand whether these protein patterns could help identify higher-risk individuals earlier, and whether interventions targeting these biological pathways might reduce heart disease in type 1 diabetes.

For now, the study reinforces what is already known: maintaining good blood sugar control and working with your healthcare team on heart health remain essential parts of long-term diabetes management.

Evidence label

Source: Cardiovascular diabetology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.